AI-generated summary
The authors compared intravenous blood laser irradiation in 46 patients with chronic nonspecific lung disease and bronchial epithelial dysplasia against 45 controls receiving routine anti-inflammatory therapy. They report full or partial regression of dysplasia in 63.1 and 17.4 percent of treated patients, versus 8.9 percent of controls, with statistically significant differences.
- Who or what was studied
- Patients with chronic nonspecific lung diseases and morphologically verified first-second degree bronchial epithelial dysplasia
- Limits stated in the abstract
- The abstract does not report wavelength, dosing, randomization, or follow-up duration, and the control group received different treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.